nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—SLCO1A2—epilepsy syndrome	0.172	0.451	CbGaD
Tolbutamide—KCNJ11—epilepsy syndrome	0.152	0.399	CbGaD
Tolbutamide—CYP2C19—epilepsy syndrome	0.0573	0.15	CbGaD
Tolbutamide—CYP2C18—Clobazam—epilepsy syndrome	0.0426	0.101	CbGbCtD
Tolbutamide—CYP2C18—Phenytoin—epilepsy syndrome	0.0316	0.0747	CbGbCtD
Tolbutamide—CYP2C18—Propofol—epilepsy syndrome	0.0295	0.0697	CbGbCtD
Tolbutamide—CYP2C18—Phenobarbital—epilepsy syndrome	0.0282	0.0666	CbGbCtD
Tolbutamide—CYP2C18—Diazepam—epilepsy syndrome	0.0267	0.0631	CbGbCtD
Tolbutamide—CYP2C18—Valproic Acid—epilepsy syndrome	0.0211	0.0498	CbGbCtD
Tolbutamide—CYP2C8—Trimethadione—epilepsy syndrome	0.0125	0.0295	CbGbCtD
Tolbutamide—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0118	0.0278	CbGbCtD
Tolbutamide—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0113	0.0267	CbGbCtD
Tolbutamide—CYP2C19—Trimethadione—epilepsy syndrome	0.0105	0.0248	CbGbCtD
Tolbutamide—CYP2C19—Felbamate—epilepsy syndrome	0.0105	0.0248	CbGbCtD
Tolbutamide—SLC22A6—Acetazolamide—epilepsy syndrome	0.0103	0.0242	CbGbCtD
Tolbutamide—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00987	0.0233	CbGbCtD
Tolbutamide—CYP2C9—Trimethadione—epilepsy syndrome	0.00873	0.0206	CbGbCtD
Tolbutamide—CYP2C19—Clobazam—epilepsy syndrome	0.00856	0.0202	CbGbCtD
Tolbutamide—CYP2C8—Carbamazepine—epilepsy syndrome	0.00845	0.02	CbGbCtD
Tolbutamide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00821	0.0194	CbGbCtD
Tolbutamide—CYP2C8—Primidone—epilepsy syndrome	0.00789	0.0186	CbGbCtD
Tolbutamide—SLC22A6—Valproic Acid—epilepsy syndrome	0.00767	0.0181	CbGbCtD
Tolbutamide—CYP2C8—Phenytoin—epilepsy syndrome	0.00758	0.0179	CbGbCtD
Tolbutamide—CYP2C19—Carbamazepine—epilepsy syndrome	0.00709	0.0167	CbGbCtD
Tolbutamide—CYP2C8—Propofol—epilepsy syndrome	0.00707	0.0167	CbGbCtD
Tolbutamide—CYP2C8—Phenobarbital—epilepsy syndrome	0.00676	0.016	CbGbCtD
Tolbutamide—CYP2C19—Primidone—epilepsy syndrome	0.00662	0.0156	CbGbCtD
Tolbutamide—CYP2C8—Diazepam—epilepsy syndrome	0.00641	0.0151	CbGbCtD
Tolbutamide—CYP2C19—Phenytoin—epilepsy syndrome	0.00636	0.015	CbGbCtD
Tolbutamide—CYP2C19—Propofol—epilepsy syndrome	0.00593	0.014	CbGbCtD
Tolbutamide—CYP2C9—Carbamazepine—epilepsy syndrome	0.0059	0.0139	CbGbCtD
Tolbutamide—CYP2C19—Phenobarbital—epilepsy syndrome	0.00567	0.0134	CbGbCtD
Tolbutamide—CYP2C9—Primidone—epilepsy syndrome	0.0055	0.013	CbGbCtD
Tolbutamide—CYP2C19—Diazepam—epilepsy syndrome	0.00537	0.0127	CbGbCtD
Tolbutamide—CYP2C9—Phenytoin—epilepsy syndrome	0.00529	0.0125	CbGbCtD
Tolbutamide—CYP2C19—Zonisamide—epilepsy syndrome	0.00525	0.0124	CbGbCtD
Tolbutamide—CYP2C8—Valproic Acid—epilepsy syndrome	0.00505	0.0119	CbGbCtD
Tolbutamide—CYP2C9—Propofol—epilepsy syndrome	0.00493	0.0116	CbGbCtD
Tolbutamide—CYP2C9—Phenobarbital—epilepsy syndrome	0.00471	0.0111	CbGbCtD
Tolbutamide—CYP2C9—Diazepam—epilepsy syndrome	0.00447	0.0106	CbGbCtD
Tolbutamide—CYP2C19—Valproic Acid—epilepsy syndrome	0.00424	0.01	CbGbCtD
Tolbutamide—CYP2C19—Topiramate—epilepsy syndrome	0.00382	0.00903	CbGbCtD
Tolbutamide—CYP2C9—Valproic Acid—epilepsy syndrome	0.00352	0.00832	CbGbCtD
Tolbutamide—SLCO2B1—ganglion—epilepsy syndrome	0.00108	0.0573	CbGeAlD
Tolbutamide—KCNJ1—forebrain—epilepsy syndrome	0.00103	0.055	CbGeAlD
Tolbutamide—KCNJ1—telencephalon—epilepsy syndrome	0.000949	0.0506	CbGeAlD
Tolbutamide—ABCC8—brainstem—epilepsy syndrome	0.000598	0.0318	CbGeAlD
Tolbutamide—KCNJ1—head—epilepsy syndrome	0.000591	0.0315	CbGeAlD
Tolbutamide—ABCC8—forebrain—epilepsy syndrome	0.000577	0.0307	CbGeAlD
Tolbutamide—KCNJ1—nervous system—epilepsy syndrome	0.00056	0.0298	CbGeAlD
Tolbutamide—KCNJ1—central nervous system—epilepsy syndrome	0.00054	0.0287	CbGeAlD
Tolbutamide—ABCC8—telencephalon—epilepsy syndrome	0.00053	0.0282	CbGeAlD
Tolbutamide—Tolazamide—KCNJ11—epilepsy syndrome	0.000481	0.137	CrCbGaD
Tolbutamide—SLCO2B1—forebrain—epilepsy syndrome	0.000451	0.024	CbGeAlD
Tolbutamide—Glisoxepide—KCNJ11—epilepsy syndrome	0.000435	0.124	CrCbGaD
Tolbutamide—Glimepiride—KCNJ11—epilepsy syndrome	0.000429	0.123	CrCbGaD
Tolbutamide—KCNJ1—brain—epilepsy syndrome	0.000428	0.0228	CbGeAlD
Tolbutamide—Hypoglycaemia—Zonisamide—epilepsy syndrome	0.00042	0.00476	CcSEcCtD
Tolbutamide—ABCC8—medulla oblongata—epilepsy syndrome	0.000417	0.0222	CbGeAlD
Tolbutamide—SLCO1A2—forebrain—epilepsy syndrome	0.000415	0.0221	CbGeAlD
Tolbutamide—Haemolytic anaemia—Carbamazepine—epilepsy syndrome	0.000415	0.0047	CcSEcCtD
Tolbutamide—SLCO2B1—telencephalon—epilepsy syndrome	0.000415	0.0221	CbGeAlD
Tolbutamide—Hyponatraemia—Zonisamide—epilepsy syndrome	0.000412	0.00466	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Acetazolamide—epilepsy syndrome	0.000411	0.00465	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Pregabalin—epilepsy syndrome	0.000408	0.00462	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Lamotrigine—epilepsy syndrome	0.000401	0.00454	CcSEcCtD
Tolbutamide—Hypoglycaemia—Oxcarbazepine—epilepsy syndrome	0.0004	0.00453	CcSEcCtD
Tolbutamide—Leukopenia—Trimethadione—epilepsy syndrome	0.000398	0.0045	CcSEcCtD
Tolbutamide—Erythema—Phenobarbital—epilepsy syndrome	0.000394	0.00446	CcSEcCtD
Tolbutamide—Hyponatraemia—Oxcarbazepine—epilepsy syndrome	0.000392	0.00444	CcSEcCtD
Tolbutamide—Pancytopenia—Levetiracetam—epilepsy syndrome	0.000384	0.00434	CcSEcCtD
Tolbutamide—Abdominal distension—Vigabatrin—epilepsy syndrome	0.000383	0.00433	CcSEcCtD
Tolbutamide—SLCO1A2—telencephalon—epilepsy syndrome	0.000382	0.0203	CbGeAlD
Tolbutamide—ABCC8—midbrain—epilepsy syndrome	0.000381	0.0203	CbGeAlD
Tolbutamide—Hyponatraemia—Carbamazepine—epilepsy syndrome	0.000376	0.00426	CcSEcCtD
Tolbutamide—Agranulocytosis—Acetazolamide—epilepsy syndrome	0.000375	0.00424	CcSEcCtD
Tolbutamide—Aplastic anaemia—Valproic Acid—epilepsy syndrome	0.000372	0.00422	CcSEcCtD
Tolbutamide—Glipizide—KCNJ11—epilepsy syndrome	0.000372	0.106	CrCbGaD
Tolbutamide—ABCC8—spinal cord—epilepsy syndrome	0.000372	0.0198	CbGeAlD
Tolbutamide—Erythema—Lacosamide—epilepsy syndrome	0.000363	0.00411	CcSEcCtD
Tolbutamide—KCNJ11—head—epilepsy syndrome	0.000359	0.0191	CbGeAlD
Tolbutamide—Photosensitivity reaction—Fosphenytoin—epilepsy syndrome	0.000356	0.00403	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Primidone—epilepsy syndrome	0.000356	0.00403	CcSEcCtD
Tolbutamide—Thrombocytopenia—Trimethadione—epilepsy syndrome	0.000355	0.00402	CcSEcCtD
Tolbutamide—Leukopenia—Rufinamide—epilepsy syndrome	0.000346	0.00391	CcSEcCtD
Tolbutamide—Gliclazide—KCNJ11—epilepsy syndrome	0.000346	0.0988	CrCbGaD
Tolbutamide—Pancytopenia—Felbamate—epilepsy syndrome	0.000344	0.00389	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Diazepam—epilepsy syndrome	0.000342	0.00387	CcSEcCtD
Tolbutamide—KCNJ11—nervous system—epilepsy syndrome	0.00034	0.0181	CbGeAlD
Tolbutamide—Pancytopenia—Zonisamide—epilepsy syndrome	0.000337	0.00381	CcSEcCtD
Tolbutamide—Agranulocytosis—Levetiracetam—epilepsy syndrome	0.000336	0.00381	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Felbamate—epilepsy syndrome	0.000331	0.00374	CcSEcCtD
Tolbutamide—ABCC8—head—epilepsy syndrome	0.00033	0.0176	CbGeAlD
Tolbutamide—KCNJ11—central nervous system—epilepsy syndrome	0.000327	0.0174	CbGeAlD
Tolbutamide—SLCO2B1—medulla oblongata—epilepsy syndrome	0.000326	0.0174	CbGeAlD
Tolbutamide—Pancytopenia—Phenytoin—epilepsy syndrome	0.000322	0.00365	CcSEcCtD
Tolbutamide—Pancytopenia—Oxcarbazepine—epilepsy syndrome	0.000321	0.00363	CcSEcCtD
Tolbutamide—KCNJ11—cerebellum—epilepsy syndrome	0.00032	0.017	CbGeAlD
Tolbutamide—SLC15A2—telencephalon—epilepsy syndrome	0.000317	0.0169	CbGeAlD
Tolbutamide—Abdominal distension—Lamotrigine—epilepsy syndrome	0.000315	0.00357	CcSEcCtD
Tolbutamide—Leukopenia—Clobazam—epilepsy syndrome	0.000315	0.00357	CcSEcCtD
Tolbutamide—ABCC8—nervous system—epilepsy syndrome	0.000313	0.0167	CbGeAlD
Tolbutamide—Agranulocytosis—Diazepam—epilepsy syndrome	0.000312	0.00353	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Phenytoin—epilepsy syndrome	0.00031	0.00351	CcSEcCtD
Tolbutamide—Thrombocytopenia—Rufinamide—epilepsy syndrome	0.000309	0.00349	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Oxcarbazepine—epilepsy syndrome	0.000308	0.00349	CcSEcCtD
Tolbutamide—Pancytopenia—Carbamazepine—epilepsy syndrome	0.000308	0.00348	CcSEcCtD
Tolbutamide—Agranulocytosis—Felbamate—epilepsy syndrome	0.000301	0.00341	CcSEcCtD
Tolbutamide—ABCC8—central nervous system—epilepsy syndrome	0.000301	0.0161	CbGeAlD
Tolbutamide—SLCO1A2—medulla oblongata—epilepsy syndrome	0.0003	0.016	CbGeAlD
Tolbutamide—Pancytopenia—Lamotrigine—epilepsy syndrome	0.000297	0.00337	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Carbamazepine—epilepsy syndrome	0.000296	0.00335	CcSEcCtD
Tolbutamide—Agranulocytosis—Zonisamide—epilepsy syndrome	0.000295	0.00334	CcSEcCtD
Tolbutamide—ABCC8—cerebellum—epilepsy syndrome	0.000295	0.0157	CbGeAlD
Tolbutamide—Erythema—Propofol—epilepsy syndrome	0.000292	0.0033	CcSEcCtD
Tolbutamide—SLCO2B1—spinal cord—epilepsy syndrome	0.000291	0.0155	CbGeAlD
Tolbutamide—Hyponatraemia—Valproic Acid—epilepsy syndrome	0.000289	0.00327	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Lamotrigine—epilepsy syndrome	0.000286	0.00324	CcSEcCtD
Tolbutamide—Erythema—Midazolam—epilepsy syndrome	0.000285	0.00323	CcSEcCtD
Tolbutamide—Agranulocytosis—Phenytoin—epilepsy syndrome	0.000283	0.0032	CcSEcCtD
Tolbutamide—Thrombocytopenia—Clobazam—epilepsy syndrome	0.000281	0.00318	CcSEcCtD
Tolbutamide—Agranulocytosis—Oxcarbazepine—epilepsy syndrome	0.000281	0.00318	CcSEcCtD
Tolbutamide—Leukopenia—Acetazolamide—epilepsy syndrome	0.000281	0.00318	CcSEcCtD
Tolbutamide—Dyspepsia—Rufinamide—epilepsy syndrome	0.000278	0.00314	CcSEcCtD
Tolbutamide—SLC22A6—brain—epilepsy syndrome	0.000275	0.0146	CbGeAlD
Tolbutamide—SLCO1A2—midbrain—epilepsy syndrome	0.000274	0.0146	CbGeAlD
Tolbutamide—Gastrointestinal disorder—Rufinamide—epilepsy syndrome	0.000272	0.00308	CcSEcCtD
Tolbutamide—Rash—Amobarbital—epilepsy syndrome	0.00027	0.00305	CcSEcCtD
Tolbutamide—Agranulocytosis—Carbamazepine—epilepsy syndrome	0.00027	0.00305	CcSEcCtD
Tolbutamide—Chlorpropamide—KCNJ11—epilepsy syndrome	0.000269	0.0768	CrCbGaD
Tolbutamide—Headache—Amobarbital—epilepsy syndrome	0.000268	0.00303	CcSEcCtD
Tolbutamide—Gliclazide—VEGFA—epilepsy syndrome	0.000268	0.0766	CrCbGaD
Tolbutamide—SLCO1A2—spinal cord—epilepsy syndrome	0.000268	0.0143	CbGeAlD
Tolbutamide—Hypoglycaemia—Pregabalin—epilepsy syndrome	0.000267	0.00302	CcSEcCtD
Tolbutamide—Hyponatraemia—Pregabalin—epilepsy syndrome	0.000261	0.00296	CcSEcCtD
Tolbutamide—Erythema—Diazepam—epilepsy syndrome	0.000261	0.00295	CcSEcCtD
Tolbutamide—Dyspepsia—Lacosamide—epilepsy syndrome	0.000261	0.00295	CcSEcCtD
Tolbutamide—Agranulocytosis—Lamotrigine—epilepsy syndrome	0.000261	0.00295	CcSEcCtD
Tolbutamide—Rash—Primidone—epilepsy syndrome	0.00026	0.00294	CcSEcCtD
Tolbutamide—KCNJ11—brain—epilepsy syndrome	0.00026	0.0138	CbGeAlD
Tolbutamide—SLCO2B1—head—epilepsy syndrome	0.000259	0.0138	CbGeAlD
Tolbutamide—Headache—Primidone—epilepsy syndrome	0.000258	0.00292	CcSEcCtD
Tolbutamide—Pruritus—Trimethadione—epilepsy syndrome	0.000257	0.0029	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Lacosamide—epilepsy syndrome	0.000256	0.00289	CcSEcCtD
Tolbutamide—Urticaria—Phenobarbital—epilepsy syndrome	0.000255	0.00289	CcSEcCtD
Tolbutamide—Nausea—Amobarbital—epilepsy syndrome	0.000254	0.00288	CcSEcCtD
Tolbutamide—Leukopenia—Levetiracetam—epilepsy syndrome	0.000252	0.00285	CcSEcCtD
Tolbutamide—Probenecid—SLCO1A2—epilepsy syndrome	0.000251	0.0717	CrCbGaD
Tolbutamide—Thrombocytopenia—Acetazolamide—epilepsy syndrome	0.000251	0.00284	CcSEcCtD
Tolbutamide—SLC15A2—medulla oblongata—epilepsy syndrome	0.000249	0.0133	CbGeAlD
Tolbutamide—Gastrointestinal disorder—Clobazam—epilepsy syndrome	0.000248	0.00281	CcSEcCtD
Tolbutamide—SLCO2B1—nervous system—epilepsy syndrome	0.000245	0.0131	CbGeAlD
Tolbutamide—Nausea—Primidone—epilepsy syndrome	0.000245	0.00277	CcSEcCtD
Tolbutamide—Hypoglycaemia—Gabapentin—epilepsy syndrome	0.000245	0.00277	CcSEcCtD
Tolbutamide—Leukopenia—Fosphenytoin—epilepsy syndrome	0.000243	0.00275	CcSEcCtD
Tolbutamide—Hyponatraemia—Gabapentin—epilepsy syndrome	0.00024	0.00271	CcSEcCtD
Tolbutamide—ABCC8—brain—epilepsy syndrome	0.000239	0.0127	CbGeAlD
Tolbutamide—SLCO1A2—head—epilepsy syndrome	0.000238	0.0127	CbGeAlD
Tolbutamide—Pancytopenia—Valproic Acid—epilepsy syndrome	0.000236	0.00268	CcSEcCtD
Tolbutamide—SLCO2B1—central nervous system—epilepsy syndrome	0.000236	0.0126	CbGeAlD
Tolbutamide—Urticaria—Lacosamide—epilepsy syndrome	0.000235	0.00266	CcSEcCtD
Tolbutamide—Leukopenia—Diazepam—epilepsy syndrome	0.000233	0.00264	CcSEcCtD
Tolbutamide—SLCO2B1—cerebellum—epilepsy syndrome	0.000231	0.0123	CbGeAlD
Tolbutamide—Rash—Trimethadione—epilepsy syndrome	0.000229	0.00259	CcSEcCtD
Tolbutamide—Urticaria—Clobazam—epilepsy syndrome	0.000228	0.00258	CcSEcCtD
Tolbutamide—SLC15A2—midbrain—epilepsy syndrome	0.000228	0.0121	CbGeAlD
Tolbutamide—Headache—Trimethadione—epilepsy syndrome	0.000227	0.00257	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Valproic Acid—epilepsy syndrome	0.000227	0.00257	CcSEcCtD
Tolbutamide—Abdominal distension—Pregabalin—epilepsy syndrome	0.000227	0.00256	CcSEcCtD
Tolbutamide—Leukopenia—Felbamate—epilepsy syndrome	0.000226	0.00256	CcSEcCtD
Tolbutamide—Erythema—Carbamazepine—epilepsy syndrome	0.000226	0.00256	CcSEcCtD
Tolbutamide—SLCO1A2—nervous system—epilepsy syndrome	0.000226	0.012	CbGeAlD
Tolbutamide—Dyspepsia—Acetazolamide—epilepsy syndrome	0.000225	0.00255	CcSEcCtD
Tolbutamide—Thrombocytopenia—Levetiracetam—epilepsy syndrome	0.000225	0.00255	CcSEcCtD
Tolbutamide—Pruritus—Rufinamide—epilepsy syndrome	0.000223	0.00253	CcSEcCtD
Tolbutamide—SLC15A2—spinal cord—epilepsy syndrome	0.000222	0.0118	CbGeAlD
Tolbutamide—Leukopenia—Zonisamide—epilepsy syndrome	0.000221	0.0025	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.000221	0.0025	CcSEcCtD
Tolbutamide—Erythema—Lamotrigine—epilepsy syndrome	0.000218	0.00247	CcSEcCtD
Tolbutamide—Thrombocytopenia—Fosphenytoin—epilepsy syndrome	0.000217	0.00246	CcSEcCtD
Tolbutamide—SLCO1A2—central nervous system—epilepsy syndrome	0.000217	0.0116	CbGeAlD
Tolbutamide—Nausea—Trimethadione—epilepsy syndrome	0.000215	0.00244	CcSEcCtD
Tolbutamide—Pancytopenia—Pregabalin—epilepsy syndrome	0.000214	0.00242	CcSEcCtD
Tolbutamide—Leukopenia—Clonazepam—epilepsy syndrome	0.000213	0.00241	CcSEcCtD
Tolbutamide—SLCO1A2—cerebellum—epilepsy syndrome	0.000212	0.0113	CbGeAlD
Tolbutamide—Leukopenia—Phenytoin—epilepsy syndrome	0.000212	0.0024	CcSEcCtD
Tolbutamide—Leukopenia—Oxcarbazepine—epilepsy syndrome	0.000211	0.00238	CcSEcCtD
Tolbutamide—Pruritus—Lacosamide—epilepsy syndrome	0.000209	0.00237	CcSEcCtD
Tolbutamide—Thrombocytopenia—Diazepam—epilepsy syndrome	0.000208	0.00236	CcSEcCtD
Tolbutamide—Agranulocytosis—Valproic Acid—epilepsy syndrome	0.000207	0.00234	CcSEcCtD
Tolbutamide—Hypoglycaemia—Topiramate—epilepsy syndrome	0.000206	0.00233	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Pregabalin—epilepsy syndrome	0.000205	0.00232	CcSEcCtD
Tolbutamide—Dyspepsia—Midazolam—epilepsy syndrome	0.000205	0.00232	CcSEcCtD
Tolbutamide—Urticaria—Acetazolamide—epilepsy syndrome	0.000203	0.0023	CcSEcCtD
Tolbutamide—Pruritus—Clobazam—epilepsy syndrome	0.000203	0.0023	CcSEcCtD
Tolbutamide—Rash—Phenobarbital—epilepsy syndrome	0.000203	0.00229	CcSEcCtD
Tolbutamide—Dyspepsia—Levetiracetam—epilepsy syndrome	0.000202	0.00229	CcSEcCtD
Tolbutamide—Leukopenia—Carbamazepine—epilepsy syndrome	0.000202	0.00229	CcSEcCtD
Tolbutamide—Thrombocytopenia—Felbamate—epilepsy syndrome	0.000202	0.00228	CcSEcCtD
Tolbutamide—Hyponatraemia—Topiramate—epilepsy syndrome	0.000202	0.00228	CcSEcCtD
Tolbutamide—Headache—Phenobarbital—epilepsy syndrome	0.000201	0.00228	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.000201	0.00227	CcSEcCtD
Tolbutamide—Rash—Rufinamide—epilepsy syndrome	0.000199	0.00225	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.000198	0.00225	CcSEcCtD
Tolbutamide—Headache—Rufinamide—epilepsy syndrome	0.000198	0.00224	CcSEcCtD
Tolbutamide—Thrombocytopenia—Zonisamide—epilepsy syndrome	0.000197	0.00223	CcSEcCtD
Tolbutamide—SLC15A2—head—epilepsy syndrome	0.000197	0.0105	CbGeAlD
Tolbutamide—Leukopenia—Lamotrigine—epilepsy syndrome	0.000195	0.00221	CcSEcCtD
Tolbutamide—Dyspepsia—Fosphenytoin—epilepsy syndrome	0.000195	0.00221	CcSEcCtD
Tolbutamide—Nausea—Phenobarbital—epilepsy syndrome	0.000191	0.00216	CcSEcCtD
Tolbutamide—Dyspepsia—Vigabatrin—epilepsy syndrome	0.00019	0.00215	CcSEcCtD
Tolbutamide—Thrombocytopenia—Clonazepam—epilepsy syndrome	0.00019	0.00215	CcSEcCtD
Tolbutamide—Thrombocytopenia—Phenytoin—epilepsy syndrome	0.000189	0.00214	CcSEcCtD
Tolbutamide—Urticaria—Propofol—epilepsy syndrome	0.000189	0.00214	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Gabapentin—epilepsy syndrome	0.000188	0.00213	CcSEcCtD
Tolbutamide—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	0.000188	0.00213	CcSEcCtD
Tolbutamide—Dyspepsia—Diazepam—epilepsy syndrome	0.000187	0.00212	CcSEcCtD
Tolbutamide—SLCO2B1—brain—epilepsy syndrome	0.000187	0.00998	CbGeAlD
Tolbutamide—Nausea—Rufinamide—epilepsy syndrome	0.000187	0.00212	CcSEcCtD
Tolbutamide—SLC15A2—nervous system—epilepsy syndrome	0.000187	0.00997	CbGeAlD
Tolbutamide—Rash—Lacosamide—epilepsy syndrome	0.000187	0.00211	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000187	0.00211	CcSEcCtD
Tolbutamide—Headache—Lacosamide—epilepsy syndrome	0.000186	0.0021	CcSEcCtD
Tolbutamide—Urticaria—Midazolam—epilepsy syndrome	0.000185	0.00209	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000184	0.00208	CcSEcCtD
Tolbutamide—Dyspepsia—Felbamate—epilepsy syndrome	0.000181	0.00205	CcSEcCtD
Tolbutamide—Rash—Clobazam—epilepsy syndrome	0.000181	0.00205	CcSEcCtD
Tolbutamide—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.00018	0.00204	CcSEcCtD
Tolbutamide—SLC15A2—central nervous system—epilepsy syndrome	0.00018	0.00959	CbGeAlD
Tolbutamide—Headache—Clobazam—epilepsy syndrome	0.00018	0.00204	CcSEcCtD
Tolbutamide—Dyspepsia—Zonisamide—epilepsy syndrome	0.000178	0.00201	CcSEcCtD
Tolbutamide—Urticaria—Fosphenytoin—epilepsy syndrome	0.000176	0.00199	CcSEcCtD
Tolbutamide—SLC15A2—cerebellum—epilepsy syndrome	0.000176	0.00938	CbGeAlD
Tolbutamide—Nausea—Lacosamide—epilepsy syndrome	0.000176	0.00199	CcSEcCtD
Tolbutamide—Abdominal distension—Topiramate—epilepsy syndrome	0.000175	0.00198	CcSEcCtD
Tolbutamide—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000174	0.00197	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000174	0.00197	CcSEcCtD
Tolbutamide—SLCO1A2—brain—epilepsy syndrome	0.000172	0.00918	CbGeAlD
Tolbutamide—Urticaria—Vigabatrin—epilepsy syndrome	0.000172	0.00194	CcSEcCtD
Tolbutamide—Dyspepsia—Clonazepam—epilepsy syndrome	0.000171	0.00194	CcSEcCtD
Tolbutamide—Nausea—Clobazam—epilepsy syndrome	0.000171	0.00193	CcSEcCtD
Tolbutamide—Dyspepsia—Phenytoin—epilepsy syndrome	0.00017	0.00192	CcSEcCtD
Tolbutamide—Urticaria—Diazepam—epilepsy syndrome	0.000169	0.00191	CcSEcCtD
Tolbutamide—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000169	0.00191	CcSEcCtD
Tolbutamide—Pruritus—Propofol—epilepsy syndrome	0.000168	0.0019	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000168	0.0019	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000167	0.00189	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000166	0.00188	CcSEcCtD
Tolbutamide—Pancytopenia—Topiramate—epilepsy syndrome	0.000165	0.00187	CcSEcCtD
Tolbutamide—Pruritus—Midazolam—epilepsy syndrome	0.000165	0.00186	CcSEcCtD
Tolbutamide—Urticaria—Felbamate—epilepsy syndrome	0.000164	0.00185	CcSEcCtD
Tolbutamide—Pruritus—Levetiracetam—epilepsy syndrome	0.000163	0.00184	CcSEcCtD
Tolbutamide—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000162	0.00184	CcSEcCtD
Tolbutamide—Headache—Acetazolamide—epilepsy syndrome	0.00016	0.00182	CcSEcCtD
Tolbutamide—Urticaria—Zonisamide—epilepsy syndrome	0.00016	0.00181	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000159	0.0018	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Topiramate—epilepsy syndrome	0.000158	0.00179	CcSEcCtD
Tolbutamide—Pruritus—Fosphenytoin—epilepsy syndrome	0.000157	0.00178	CcSEcCtD
Tolbutamide—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000157	0.00177	CcSEcCtD
Tolbutamide—Leukopenia—Valproic Acid—epilepsy syndrome	0.000155	0.00176	CcSEcCtD
Tolbutamide—Urticaria—Clonazepam—epilepsy syndrome	0.000154	0.00175	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000154	0.00174	CcSEcCtD
Tolbutamide—Urticaria—Phenytoin—epilepsy syndrome	0.000153	0.00174	CcSEcCtD
Tolbutamide—Pruritus—Vigabatrin—epilepsy syndrome	0.000153	0.00173	CcSEcCtD
Tolbutamide—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000153	0.00173	CcSEcCtD
Tolbutamide—Nausea—Acetazolamide—epilepsy syndrome	0.000152	0.00172	CcSEcCtD
Tolbutamide—Pruritus—Diazepam—epilepsy syndrome	0.000151	0.0017	CcSEcCtD
Tolbutamide—Rash—Propofol—epilepsy syndrome	0.00015	0.0017	CcSEcCtD
Tolbutamide—Headache—Propofol—epilepsy syndrome	0.000149	0.00169	CcSEcCtD
Tolbutamide—Rash—Midazolam—epilepsy syndrome	0.000147	0.00166	CcSEcCtD
Tolbutamide—Urticaria—Carbamazepine—epilepsy syndrome	0.000146	0.00166	CcSEcCtD
Tolbutamide—Headache—Midazolam—epilepsy syndrome	0.000146	0.00165	CcSEcCtD
Tolbutamide—Pruritus—Felbamate—epilepsy syndrome	0.000146	0.00165	CcSEcCtD
Tolbutamide—Rash—Levetiracetam—epilepsy syndrome	0.000145	0.00164	CcSEcCtD
Tolbutamide—Agranulocytosis—Topiramate—epilepsy syndrome	0.000144	0.00163	CcSEcCtD
Tolbutamide—Headache—Levetiracetam—epilepsy syndrome	0.000144	0.00163	CcSEcCtD
Tolbutamide—Erythema—Gabapentin—epilepsy syndrome	0.000144	0.00163	CcSEcCtD
Tolbutamide—SLC15A2—brain—epilepsy syndrome	0.000143	0.00762	CbGeAlD
Tolbutamide—Pruritus—Zonisamide—epilepsy syndrome	0.000143	0.00161	CcSEcCtD
Tolbutamide—Urticaria—Lamotrigine—epilepsy syndrome	0.000142	0.0016	CcSEcCtD
Tolbutamide—Nausea—Propofol—epilepsy syndrome	0.000141	0.0016	CcSEcCtD
Tolbutamide—Leukopenia—Pregabalin—epilepsy syndrome	0.00014	0.00159	CcSEcCtD
Tolbutamide—Rash—Fosphenytoin—epilepsy syndrome	0.00014	0.00158	CcSEcCtD
Tolbutamide—Headache—Fosphenytoin—epilepsy syndrome	0.000139	0.00157	CcSEcCtD
Tolbutamide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000139	0.00157	CcSEcCtD
Tolbutamide—Nausea—Midazolam—epilepsy syndrome	0.000138	0.00156	CcSEcCtD
Tolbutamide—Pruritus—Clonazepam—epilepsy syndrome	0.000138	0.00156	CcSEcCtD
Tolbutamide—Pruritus—Phenytoin—epilepsy syndrome	0.000137	0.00155	CcSEcCtD
Tolbutamide—Nausea—Levetiracetam—epilepsy syndrome	0.000137	0.00155	CcSEcCtD
Tolbutamide—Rash—Vigabatrin—epilepsy syndrome	0.000136	0.00154	CcSEcCtD
Tolbutamide—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000136	0.00154	CcSEcCtD
Tolbutamide—Headache—Vigabatrin—epilepsy syndrome	0.000135	0.00153	CcSEcCtD
Tolbutamide—Rash—Diazepam—epilepsy syndrome	0.000134	0.00152	CcSEcCtD
Tolbutamide—Headache—Diazepam—epilepsy syndrome	0.000133	0.00151	CcSEcCtD
Tolbutamide—Nausea—Fosphenytoin—epilepsy syndrome	0.000132	0.00149	CcSEcCtD
Tolbutamide—Pruritus—Carbamazepine—epilepsy syndrome	0.00013	0.00148	CcSEcCtD
Tolbutamide—Rash—Felbamate—epilepsy syndrome	0.00013	0.00147	CcSEcCtD
Tolbutamide—Gliclazide—CYP2C19—epilepsy syndrome	0.00013	0.0371	CrCbGaD
Tolbutamide—Headache—Felbamate—epilepsy syndrome	0.000129	0.00146	CcSEcCtD
Tolbutamide—Leukopenia—Gabapentin—epilepsy syndrome	0.000129	0.00146	CcSEcCtD
Tolbutamide—Nausea—Vigabatrin—epilepsy syndrome	0.000128	0.00145	CcSEcCtD
Tolbutamide—Rash—Zonisamide—epilepsy syndrome	0.000127	0.00144	CcSEcCtD
Tolbutamide—Nausea—Diazepam—epilepsy syndrome	0.000126	0.00143	CcSEcCtD
Tolbutamide—Headache—Zonisamide—epilepsy syndrome	0.000126	0.00143	CcSEcCtD
Tolbutamide—Pruritus—Lamotrigine—epilepsy syndrome	0.000126	0.00143	CcSEcCtD
Tolbutamide—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000125	0.00142	CcSEcCtD
Tolbutamide—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000125	0.00141	CcSEcCtD
Tolbutamide—Rash—Clonazepam—epilepsy syndrome	0.000123	0.00139	CcSEcCtD
Tolbutamide—Nausea—Felbamate—epilepsy syndrome	0.000122	0.00139	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000122	0.00138	CcSEcCtD
Tolbutamide—Headache—Clonazepam—epilepsy syndrome	0.000122	0.00138	CcSEcCtD
Tolbutamide—Rash—Phenytoin—epilepsy syndrome	0.000122	0.00138	CcSEcCtD
Tolbutamide—Rash—Oxcarbazepine—epilepsy syndrome	0.000121	0.00137	CcSEcCtD
Tolbutamide—Headache—Phenytoin—epilepsy syndrome	0.000121	0.00137	CcSEcCtD
Tolbutamide—Erythema—Topiramate—epilepsy syndrome	0.000121	0.00137	CcSEcCtD
Tolbutamide—CYP2C8—brain—epilepsy syndrome	0.00012	0.00641	CbGeAlD
Tolbutamide—Headache—Oxcarbazepine—epilepsy syndrome	0.00012	0.00136	CcSEcCtD
Tolbutamide—Probenecid—ABCC2—epilepsy syndrome	0.00012	0.0343	CrCbGaD
Tolbutamide—Nausea—Zonisamide—epilepsy syndrome	0.00012	0.00136	CcSEcCtD
Tolbutamide—Rash—Carbamazepine—epilepsy syndrome	0.000116	0.00132	CcSEcCtD
Tolbutamide—Nausea—Clonazepam—epilepsy syndrome	0.000115	0.00131	CcSEcCtD
Tolbutamide—Headache—Carbamazepine—epilepsy syndrome	0.000115	0.00131	CcSEcCtD
Tolbutamide—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000115	0.0013	CcSEcCtD
Tolbutamide—Nausea—Phenytoin—epilepsy syndrome	0.000115	0.0013	CcSEcCtD
Tolbutamide—Nausea—Oxcarbazepine—epilepsy syndrome	0.000114	0.00129	CcSEcCtD
Tolbutamide—Urticaria—Valproic Acid—epilepsy syndrome	0.000112	0.00127	CcSEcCtD
Tolbutamide—Rash—Lamotrigine—epilepsy syndrome	0.000112	0.00127	CcSEcCtD
Tolbutamide—Headache—Lamotrigine—epilepsy syndrome	0.000112	0.00126	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.00011	0.00125	CcSEcCtD
Tolbutamide—Nausea—Carbamazepine—epilepsy syndrome	0.000109	0.00124	CcSEcCtD
Tolbutamide—Leukopenia—Topiramate—epilepsy syndrome	0.000108	0.00123	CcSEcCtD
Tolbutamide—Nausea—Lamotrigine—epilepsy syndrome	0.000106	0.0012	CcSEcCtD
Tolbutamide—Dyspepsia—Gabapentin—epilepsy syndrome	0.000103	0.00117	CcSEcCtD
Tolbutamide—Urticaria—Pregabalin—epilepsy syndrome	0.000102	0.00115	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000101	0.00115	CcSEcCtD
Tolbutamide—Chlorpropamide—CYP2C19—epilepsy syndrome	0.000101	0.0289	CrCbGaD
Tolbutamide—Pruritus—Valproic Acid—epilepsy syndrome	0.0001	0.00113	CcSEcCtD
Tolbutamide—Thrombocytopenia—Topiramate—epilepsy syndrome	9.67e-05	0.00109	CcSEcCtD
Tolbutamide—Urticaria—Gabapentin—epilepsy syndrome	9.32e-05	0.00105	CcSEcCtD
Tolbutamide—Pruritus—Pregabalin—epilepsy syndrome	9.05e-05	0.00102	CcSEcCtD
Tolbutamide—Rash—Valproic Acid—epilepsy syndrome	8.92e-05	0.00101	CcSEcCtD
Tolbutamide—Headache—Valproic Acid—epilepsy syndrome	8.87e-05	0.001	CcSEcCtD
Tolbutamide—Dyspepsia—Topiramate—epilepsy syndrome	8.69e-05	0.000983	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	8.52e-05	0.000965	CcSEcCtD
Tolbutamide—Nausea—Valproic Acid—epilepsy syndrome	8.41e-05	0.000952	CcSEcCtD
Tolbutamide—Probenecid—CYP2C19—epilepsy syndrome	8.35e-05	0.0238	CrCbGaD
Tolbutamide—Pruritus—Gabapentin—epilepsy syndrome	8.3e-05	0.00094	CcSEcCtD
Tolbutamide—Rash—Pregabalin—epilepsy syndrome	8.07e-05	0.000913	CcSEcCtD
Tolbutamide—Headache—Pregabalin—epilepsy syndrome	8.02e-05	0.000907	CcSEcCtD
Tolbutamide—Urticaria—Topiramate—epilepsy syndrome	7.84e-05	0.000888	CcSEcCtD
Tolbutamide—Nausea—Pregabalin—epilepsy syndrome	7.6e-05	0.00086	CcSEcCtD
Tolbutamide—Rash—Gabapentin—epilepsy syndrome	7.4e-05	0.000837	CcSEcCtD
Tolbutamide—Headache—Gabapentin—epilepsy syndrome	7.35e-05	0.000832	CcSEcCtD
Tolbutamide—Gliclazide—ALB—epilepsy syndrome	7.21e-05	0.0206	CrCbGaD
Tolbutamide—Pruritus—Topiramate—epilepsy syndrome	6.98e-05	0.00079	CcSEcCtD
Tolbutamide—Nausea—Gabapentin—epilepsy syndrome	6.97e-05	0.000789	CcSEcCtD
Tolbutamide—Rash—Topiramate—epilepsy syndrome	6.22e-05	0.000704	CcSEcCtD
Tolbutamide—Headache—Topiramate—epilepsy syndrome	6.18e-05	0.0007	CcSEcCtD
Tolbutamide—Nausea—Topiramate—epilepsy syndrome	5.86e-05	0.000664	CcSEcCtD
Tolbutamide—Chlorpropamide—ABCB1—epilepsy syndrome	5.35e-05	0.0153	CrCbGaD
Tolbutamide—Probenecid—ALB—epilepsy syndrome	4.63e-05	0.0132	CrCbGaD
Tolbutamide—Probenecid—ABCB1—epilepsy syndrome	4.42e-05	0.0126	CrCbGaD
Tolbutamide—CYP2C19—Metabolism—PNPO—epilepsy syndrome	7.86e-06	9.4e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NHLRC1—epilepsy syndrome	7.86e-06	9.4e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PLCB1—epilepsy syndrome	7.86e-06	9.4e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	7.84e-06	9.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	7.84e-06	9.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CERS1—epilepsy syndrome	7.84e-06	9.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PDXK—epilepsy syndrome	7.84e-06	9.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—FAR1—epilepsy syndrome	7.84e-06	9.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ADK—epilepsy syndrome	7.84e-06	9.37e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—TH—epilepsy syndrome	7.83e-06	9.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ABCG2—epilepsy syndrome	7.83e-06	9.37e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—SLC2A1—epilepsy syndrome	7.71e-06	9.21e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—COX3—epilepsy syndrome	7.7e-06	9.21e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP2C19—epilepsy syndrome	7.63e-06	9.13e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PLCB1—epilepsy syndrome	7.62e-06	9.11e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—TH—epilepsy syndrome	7.6e-06	9.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP11A1—epilepsy syndrome	7.59e-06	9.07e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.58e-06	9.06e-05	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.55e-06	9.02e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.43e-06	8.88e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CA4—epilepsy syndrome	7.31e-06	8.74e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—QDPR—epilepsy syndrome	7.31e-06	8.74e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—KCNB1—epilepsy syndrome	7.3e-06	8.73e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLCO1A2—epilepsy syndrome	7.3e-06	8.73e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CACNA2D2—epilepsy syndrome	7.3e-06	8.73e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC6A8—epilepsy syndrome	7.3e-06	8.73e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PFKL—epilepsy syndrome	7.3e-06	8.73e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—POMC—epilepsy syndrome	7.29e-06	8.71e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	7.17e-06	8.57e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GAMT—epilepsy syndrome	7.17e-06	8.57e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PNPO—epilepsy syndrome	7.17e-06	8.57e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	7.17e-06	8.57e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	7.13e-06	8.53e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	7.09e-06	8.48e-05	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7e-06	8.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—COX3—epilepsy syndrome	6.87e-06	8.22e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP2D6—epilepsy syndrome	6.85e-06	8.19e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—UPB1—epilepsy syndrome	6.68e-06	7.98e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NEU1—epilepsy syndrome	6.68e-06	7.98e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ATIC—epilepsy syndrome	6.68e-06	7.98e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CA4—epilepsy syndrome	6.66e-06	7.97e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—QDPR—epilepsy syndrome	6.66e-06	7.97e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	6.64e-06	7.94e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ABCG2—epilepsy syndrome	6.63e-06	7.93e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—HMOX1—epilepsy syndrome	6.54e-06	7.82e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ADRA2A—epilepsy syndrome	6.52e-06	7.79e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	6.51e-06	7.79e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	6.51e-06	7.79e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PFKL—epilepsy syndrome	6.51e-06	7.79e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	6.51e-06	7.79e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	6.51e-06	7.79e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—BCHE—epilepsy syndrome	6.49e-06	7.76e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP2C19—epilepsy syndrome	6.47e-06	7.73e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CAT—epilepsy syndrome	6.45e-06	7.71e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HSD17B4—epilepsy syndrome	6.43e-06	7.68e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP11A1—epilepsy syndrome	6.43e-06	7.68e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.38e-06	7.63e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—HMOX1—epilepsy syndrome	6.34e-06	7.58e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	6.33e-06	7.57e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ABCB1—epilepsy syndrome	6.27e-06	7.5e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—COX3—epilepsy syndrome	6.27e-06	7.49e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CAT—epilepsy syndrome	6.25e-06	7.48e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GBE1—epilepsy syndrome	6.21e-06	7.42e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PPP1R3C—epilepsy syndrome	6.21e-06	7.42e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—SLC2A1—epilepsy syndrome	6.19e-06	7.4e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PLCB1—epilepsy syndrome	6.12e-06	7.32e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—TH—epilepsy syndrome	6.1e-06	7.3e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ABCB1—epilepsy syndrome	6.08e-06	7.27e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.07e-06	7.25e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NEU1—epilepsy syndrome	5.96e-06	7.12e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—UPB1—epilepsy syndrome	5.96e-06	7.12e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ATIC—epilepsy syndrome	5.96e-06	7.12e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	5.94e-06	7.1e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	5.94e-06	7.1e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	5.94e-06	7.1e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PFKL—epilepsy syndrome	5.94e-06	7.1e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	5.94e-06	7.1e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ASAH1—epilepsy syndrome	5.84e-06	6.98e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GPX1—epilepsy syndrome	5.83e-06	6.97e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.82e-06	6.95e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	5.81e-06	6.94e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP2D6—epilepsy syndrome	5.8e-06	6.93e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	5.77e-06	6.9e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	5.74e-06	6.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—STXBP1—epilepsy syndrome	5.68e-06	6.79e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GPX1—epilepsy syndrome	5.66e-06	6.76e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GBE1—epilepsy syndrome	5.54e-06	6.62e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	5.54e-06	6.62e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NT5E—epilepsy syndrome	5.53e-06	6.61e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ALAD—epilepsy syndrome	5.53e-06	6.61e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.53e-06	6.61e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ADRA2A—epilepsy syndrome	5.52e-06	6.6e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—BCHE—epilepsy syndrome	5.5e-06	6.57e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—UPB1—epilepsy syndrome	5.43e-06	6.5e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ATIC—epilepsy syndrome	5.43e-06	6.5e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NEU1—epilepsy syndrome	5.43e-06	6.5e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	5.41e-06	6.47e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	5.28e-06	6.31e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	5.28e-06	6.31e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SLC2A1—epilepsy syndrome	5.24e-06	6.27e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	5.23e-06	6.25e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	5.21e-06	6.23e-05	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.2e-06	6.22e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PLCB1—epilepsy syndrome	5.19e-06	6.2e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—TH—epilepsy syndrome	5.17e-06	6.18e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	5.16e-06	6.17e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AGT—epilepsy syndrome	5.11e-06	6.12e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—HMOX1—epilepsy syndrome	5.09e-06	6.09e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.09e-06	6.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	5.07e-06	6.06e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ADSL—epilepsy syndrome	5.06e-06	6.05e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GBE1—epilepsy syndrome	5.05e-06	6.04e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	5.05e-06	6.04e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CAT—epilepsy syndrome	5.02e-06	6.01e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—APOE—epilepsy syndrome	5.01e-06	5.99e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GLUL—epilepsy syndrome	4.96e-06	5.93e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AGT—epilepsy syndrome	4.96e-06	5.93e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ALAD—epilepsy syndrome	4.94e-06	5.9e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NT5E—epilepsy syndrome	4.94e-06	5.9e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	4.94e-06	5.9e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ABCB1—epilepsy syndrome	4.89e-06	5.84e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	4.87e-06	5.82e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—APOE—epilepsy syndrome	4.86e-06	5.81e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	4.75e-06	5.68e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	4.71e-06	5.63e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	4.71e-06	5.63e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	4.62e-06	5.52e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	4.61e-06	5.51e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	4.56e-06	5.45e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GPX1—epilepsy syndrome	4.54e-06	5.43e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ADSL—epilepsy syndrome	4.52e-06	5.4e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ALAD—epilepsy syndrome	4.5e-06	5.38e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NT5E—epilepsy syndrome	4.5e-06	5.38e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GLUL—epilepsy syndrome	4.43e-06	5.3e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AQP1—epilepsy syndrome	4.42e-06	5.29e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	4.35e-06	5.2e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—HMOX1—epilepsy syndrome	4.31e-06	5.16e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—POMC—epilepsy syndrome	4.31e-06	5.15e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	4.29e-06	5.14e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	4.29e-06	5.14e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CAT—epilepsy syndrome	4.26e-06	5.09e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.25e-06	5.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	4.2e-06	5.03e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—POMC—epilepsy syndrome	4.17e-06	4.99e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ABCB1—epilepsy syndrome	4.14e-06	4.95e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ADSL—epilepsy syndrome	4.12e-06	4.92e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	4.07e-06	4.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	4.04e-06	4.83e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	4e-06	4.78e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	4e-06	4.78e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AGT—epilepsy syndrome	3.98e-06	4.76e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	3.96e-06	4.74e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AQP1—epilepsy syndrome	3.95e-06	4.72e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ALB—epilepsy syndrome	3.93e-06	4.69e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—APOE—epilepsy syndrome	3.9e-06	4.67e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GPX1—epilepsy syndrome	3.85e-06	4.6e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ALB—epilepsy syndrome	3.81e-06	4.55e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.79e-06	4.53e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.72e-06	4.45e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	3.71e-06	4.43e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.65e-06	4.36e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	3.6e-06	4.3e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	3.57e-06	4.27e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	3.57e-06	4.27e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.46e-06	4.13e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTGS2—epilepsy syndrome	3.43e-06	4.11e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AGT—epilepsy syndrome	3.38e-06	4.04e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—POMC—epilepsy syndrome	3.35e-06	4.01e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTGS2—epilepsy syndrome	3.33e-06	3.98e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.32e-06	3.97e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—APOE—epilepsy syndrome	3.31e-06	3.95e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	3.26e-06	3.9e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.26e-06	3.89e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.25e-06	3.89e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.25e-06	3.89e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	3.18e-06	3.8e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	3.16e-06	3.78e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.13e-06	3.75e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ALB—epilepsy syndrome	3.06e-06	3.66e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.03e-06	3.62e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.97e-06	3.55e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	2.91e-06	3.48e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.86e-06	3.42e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.85e-06	3.41e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—POMC—epilepsy syndrome	2.84e-06	3.4e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	2.82e-06	3.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.8e-06	3.35e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	2.71e-06	3.24e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—BCHE—epilepsy syndrome	2.7e-06	3.23e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTGS2—epilepsy syndrome	2.68e-06	3.2e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.65e-06	3.17e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ALB—epilepsy syndrome	2.59e-06	3.1e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.59e-06	3.09e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	2.58e-06	3.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.57e-06	3.07e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.55e-06	3.05e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.55e-06	3.05e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	2.55e-06	3.05e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.54e-06	3.04e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TH—epilepsy syndrome	2.54e-06	3.04e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.5e-06	2.99e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.42e-06	2.9e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.41e-06	2.88e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.33e-06	2.78e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.32e-06	2.77e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2.3e-06	2.75e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2.28e-06	2.72e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TH—epilepsy syndrome	2.27e-06	2.71e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	2.27e-06	2.71e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.23e-06	2.67e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.21e-06	2.64e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.2e-06	2.63e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.12e-06	2.53e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.1e-06	2.51e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.09e-06	2.5e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.07e-06	2.48e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TH—epilepsy syndrome	2.07e-06	2.47e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.03e-06	2.43e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	2.03e-06	2.43e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.89e-06	2.26e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.89e-06	2.26e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.87e-06	2.23e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.82e-06	2.17e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AKT1—epilepsy syndrome	1.73e-06	2.06e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.73e-06	2.06e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.7e-06	2.04e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.69e-06	2.02e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AKT1—epilepsy syndrome	1.67e-06	2e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.66e-06	1.98e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.66e-06	1.98e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.63e-06	1.94e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.54e-06	1.84e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.48e-06	1.77e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.45e-06	1.73e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.4e-06	1.67e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.35e-06	1.61e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AKT1—epilepsy syndrome	1.34e-06	1.61e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.32e-06	1.58e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.27e-06	1.52e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.25e-06	1.49e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	1.14e-06	1.36e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.14e-06	1.36e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.14e-06	1.36e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.11e-06	1.33e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.04e-06	1.24e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	9.94e-07	1.19e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	9.06e-07	1.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AKT1—epilepsy syndrome	5.6e-07	6.69e-06	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AKT1—epilepsy syndrome	5e-07	5.97e-06	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4.55e-07	5.45e-06	CbGpPWpGaD
